Cargando…
Perturbation of DNA repair pathways by proteasome inhibitors corresponds to enhanced chemosensitivity of cells to DNA damage-inducing agents
PURPOSE: Breast cancer treatment often employs DNA double-strand breaks (DSBs), such as that induced by irradiation or anticancer agents. Ubiquitination is required at the site of DNA damage and plays a crucial role in the DSB repair pathway. We investigated the effect of proteasome inhibitors on th...
Autores principales: | Takeshita, Takashi, Wu, Wenwen, Koike, Ayaka, Fukuda, Mamoru, Ohta, Tomohiko |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2728221/ https://www.ncbi.nlm.nih.gov/pubmed/19274461 http://dx.doi.org/10.1007/s00280-009-0961-5 |
Ejemplares similares
-
Prediction of breast cancer sensitivity to neoadjuvant chemotherapy based on status of DNA damage repair proteins
por: Asakawa, Hideki, et al.
Publicado: (2010) -
The ubiquitin E3 ligase activity of BRCA1 and its biological functions
por: Wu, Wenwen, et al.
Publicado: (2008) -
Mutated DNA Damage Repair Pathways Are Prognostic and Chemosensitivity Markers for Resected Colorectal Cancer Liver Metastases
por: Wang, Kun, et al.
Publicado: (2021) -
DNA Damage Induced by Alkylating Agents and Repair Pathways
por: Kondo, Natsuko, et al.
Publicado: (2010) -
Class I histone deacetylase inhibitors inhibit the retention of BRCA1 and 53BP1 at the site of DNA damage
por: Fukuda, Takayo, et al.
Publicado: (2015)